Midostaurin is an oral, first-generation, multi-targeted kinase inhibitor that potently inhibits FLT3, KIT, and other kinases, used in combination with chemotherapy for the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia (AML).
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea